Article Text

Download PDFPDF
Unexpected outcome (positive or negative) including adverse drug reactions
Probable hepatotoxicity associated with the use of metformin in type 2 diabetes
  1. Taqi Hashmi
  1. Family Medicine Department, King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia
  1. Correspondence to Dr Taqi Hashmi MB BChir MA (Cantab) MRCGP, taqi{at}lamika.com

Summary

This is a case report of a 44-year-old obese female who developed subclinical hepatic injury 4 weeks after starting metformin for type 2 diabetes. She had a rise in her alanine aminotransferase which peaked at 5 months (738 U/l) and rapidly declined within days of discontinuing her metformin. No other positive evidence of alternative causes for the hepatic injury was found. The likelihood of metformin-induced injury was 7 on the Naranjo scale of adverse drug reactions. A brief review of the 11 previously reported cases in the English medical literature is also made.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Competing interests None.

  • Patient consent Obtained.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.